Researchers led by Osaka University in Japan have conducted the first human trial using induced pluripotent stem-cell-derived ...

Researchers found that neural crest stem cells are uniquely capable of reprogramming, challenging current reprogramming ...

The University of Texas MD Anderson Cancer Center today announced the launch of its Institute for Cell Therapy Discovery & Innovation, which will build upon longstanding MD Anderson clinical and ...

A new therapy may delay Alzheimer's disease progression by years, according to a study by researchers at Texas A&M University ...

PHAT is a facial rejuvenation therapy that combines nanofat and its stem cells with PRP for anti-aging that lasts for more ...

New data publishing 11/11 in Cell Stem Cell provides strong support for the first-in-human universal gene therapy trial for DBA through regulated GATA1 expression. Notably, it’s one of the first ...

The largest ever clinical trial of T cell therapy for solid tumors has ended, heralding a new era for precision T cell therapy.

European regulators has recommended an advanced stem cell therapy which prevents immune reactions following blood cancer stem cell transplants. MolMed’s Zalmoxis is an add-on treatment for ...

have relapsed or refractory ALL after at least two previous lines of therapy, or have disease that relapsed or was refractory ...

Bayer subsidiary BlueRock Therapeutics has been granted a fast-track review by the FDA for DA01, its stem cell-based therapy for Parkinson's disease which is currently in early-stage clinical testing.

Women in science, technology, engineering and mathematics (STEM) face numerous challenges in their early careers which often have long-lasting impacts on their professional journeys. Despite ...

Pluripotent stem cells are cells that have the capacity to self-renew by dividing and to develop into the three primary germ cell layers of the early embryo and therefore into all cells of the ...